Monday, November 21, 2016

UPDATE 1-Novartis buys US blood disease drugmaker in $665 mln deal

* Study results for drug being acquired due Dec. 4

(Adds analyst comment, details, background, shares)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)